We are live on
!
Find out more
ZIC
ZWJ Investment Counsel Portfolio holdings
AUM
$3.09B
1-Year Est. Return
39.43%
This Fund
S&P 500
This Quarter
Est. Return
+7.89%
1 Year Est. Return
+39.43%
3 Year Est. Return
+115.09%
5 Year Est. Return
+149.82%
10 Year Est. Return
+2,238.52%
AUM
$1.49B
AUM Growth
+$204M
(+16%)
Cap. Flow
+$111M
Cap. Flow
% of AUM
7.49%
Top 10 Holdings %
Top 10 Hldgs %
29.03%
Holding
222
New
69
Increased
78
Reduced
55
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Genuine Parts
GPC
|
+$49.6M |
| 2 |
International Flavors & Fragrances
IFF
|
+$16.6M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$11M |
| 4 |
Johnson & Johnson
JNJ
|
+$8.93M |
| 5 |
Norfolk Southern
NSC
|
+$8.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$21M |
| 2 |
Ingredion
INGR
|
+$5.31M |
| 3 |
FedEx
FDX
|
+$4.35M |
| 4 |
Corteva
CTVA
|
+$3.83M |
| 5 |
Kayne Anderson Energy Infrastructure Fund
KYN
|
+$3.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.99% |
| 2 | Healthcare | 14.36% |
| 3 | Financials | 12.17% |
| 4 | Consumer Staples | 11.89% |
| 5 | Communication Services | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Starbucks
SBUX
$122B
| $743K | 0.05% |
8,453
+4,444
| +111% | +$379K |
|
127
Eli Lilly
LLY
$1.08T
| $734K | 0.05% |
5,588
+313
| +6% | +$36.3K |
|
128
Citigroup
C
$228B
| $721K | 0.05% |
+9,029
| New | +$667K |
|
129
Amgen
AMGN
$224B
| $718K | 0.05% |
2,977
+123
| +4% | +$27.1K |
|
130
Medtronic
MDT
$116B
| $699K | 0.05% |
+6,157
| New | +$676K |
|
131
iShares Global Healthcare ETF
IXJ
$4.23B
| $688K | 0.05% |
+10,000
| New | +$649K |
|
132
Adobe
ADBE
$105B
| $671K | 0.05% |
2,036
+1,051
| +107% | +$309K |
|
133
iShares US Aerospace & Defense ETF
ITA
$15B
| $668K | 0.05% |
+6,020
| New | +$676K |
|
|
RDS.B
134
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $653K | 0.04% |
+10,886
| New | +$641K |
|
135
TJX Companies
TJX
$172B
| $648K | 0.04% |
+10,605
| New | +$627K |
|
136
Delta Air Lines
DAL
$59.5B
| $646K | 0.04% |
+11,053
| New | +$620K |
|
137
Invesco QQQ Trust
QQQ
$478B
| $638K | 0.04% |
+3,000
| New | +$601K |
|
138
Target
TGT
$69.2B
| $616K | 0.04% |
4,801
+1,458
| +44% | +$171K |
|
139
iShares Russell 1000 Value ETF
IWD
$84B
| $584K | 0.04% |
+4,281
| New | +$564K |
|
|
BMY.RT
140
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $579K | 0.04% |
+192,419
| New | +$500K |
|
141
Synchrony
SYF
$25.5B
| $575K | 0.04% |
+15,955
| New | +$571K |
|
142
Vanguard Information Technology ETF
VGT
$147B
| $573K | 0.04% |
+18,720
| New | +$536K |
|
143
Ross Stores
ROST
$80.8B
| $543K | 0.04% |
+4,666
| New | +$525K |
|
144
Cboe Global Markets
CBOE
$29.5B
| $540K | 0.04% |
4,500
| – | – |
|
145
Fidelity National Financial
FNF
$12.8B
| $530K | 0.04% |
+12,153
| New | +$539K |
|
146
AutoZone
AZO
$49.7B
| $523K | 0.04% |
+439
| New | +$507K |
|
147
Zoetis
ZTS
$31.1B
| $521K | 0.04% |
+3,933
| New | +$489K |
|
148
Phillips 66
PSX
$89.5B
| $502K | 0.03% |
+4,510
| New | +$507K |
|
149
Everest Group
EG
$14B
| $490K | 0.03% |
+1,771
| New | +$467K |
|
|
NVO
150
Novo Nordisk
NVO
$207B
| $485K | 0.03% |
+16,772
| New | +$464K |
|
Similar funds
HCM
TCG
CAM
MRCP
PC
ECP
CCI
DIG
ZWJ Investment Counsel's Q4 2019 Portfolio in Review
As of Q4 2019, ZWJ Investment Counsel held 222 positions worth $1.49B, up 16% from $1.28B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
ZWJ Investment Counsel deployed $111M of net new capital in Q4 2019, opening 69 new positions and adding to 78 existing holdings. Its largest new stake was International Flavors & Fragrances: 129,832 shares worth $16.8M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ingredion, an estimated $5.31M trimmed.
- ZWJ Investment Counsel's largest Q4 2019 buy was International Flavors & Fragrances: 129,832 shares worth $16.8M.
- ZWJ Investment Counsel added most to Genuine Parts in Q4 2019, an estimated $49.6M increase.
- ZWJ Investment Counsel's biggest Q4 2019 reduction was Ingredion, cutting an estimated $5.31M.
- ZWJ Investment Counsel fully exited Celgene Corp in Q4 2019, selling an estimated $21M.
- ZWJ Investment Counsel's ten largest holdings make up 29% of its $1.49B portfolio in Q4 2019.
- ZWJ Investment Counsel opened 69 new positions and closed 10 in Q4 2019.
- ZWJ Investment Counsel's portfolio value rose 16% quarter-over-quarter to $1.49B.
Based on ZWJ Investment Counsel's 13F filing for Q4 2019, filed 13 Feb 2020.